REMINYL PROLONGED RELEASE CAPSULE 16 MG
Product details
Registration number: SIN13020P
Classification: Prescription Only
Active ingredients: GALANTAMINE HBR20.51 MG EQV GALANTAMINE BASE
Strength: 16 MG
Dosage form: CAPSULE, COATED, EXTENDED RELEASE
Route: ORAL
Registrant: APEX PHARMA MARKETING PTE. LTD.
ATC code: N06DA04
HSA approval date: 10 August 2004
Manufacturer(s):
- JANSSEN PHARMACEUTICA NV
- JANSSEN-CILAG SPA (Encapsulation)
Manufacturing country/countries: BELGIUM; ITALY
What are the HSA registration number and classification for REMINYL PROLONGED RELEASE CAPSULE 16 MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13020P
Classification: Prescription Only
What active ingredients and strength are recorded for REMINYL PROLONGED RELEASE CAPSULE 16 MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: GALANTAMINE HBR20.51 MG EQV GALANTAMINE BASE
Strength: 16 MG
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for REMINYL PROLONGED RELEASE CAPSULE 16 MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE, COATED, EXTENDED RELEASE
Route: ORAL
Who is the recorded registrant for REMINYL PROLONGED RELEASE CAPSULE 16 MG?
According to the HSA dataset updated 7 August 2026:
Registrant: APEX PHARMA MARKETING PTE. LTD.
Which manufacturers and countries are listed for REMINYL PROLONGED RELEASE CAPSULE 16 MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- JANSSEN PHARMACEUTICA NV
- JANSSEN-CILAG SPA (Encapsulation)
Manufacturing country/countries: BELGIUM; ITALY
Where can I look up REMINYL PROLONGED RELEASE CAPSULE 16 MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13020P or the exact product name REMINYL PROLONGED RELEASE CAPSULE 16 MG. The general register link does not preselect this product.
What are the source dates for this REMINYL PROLONGED RELEASE CAPSULE 16 MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this REMINYL PROLONGED RELEASE CAPSULE 16 MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13020P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)